Our new analysis platform COVIDOUTCOME can link mutation in SARS-CoV-2 to clinical outcome - click image to visit site.

Nagy et al: Different mutations in SARS-CoV-2 associate with severe and mild outcome. Int J Antimicrob Agents (2021)

Menyhárt and Győrffy: Multi-omics approaches in cancer research with applications in tumor subtyping, prognosis, and diagnosis, Computational and Structural Biotechnology Journal (2021)

Nagy and Győrffy: muTarget: A platform linking gene expression changes and mutation status in solid tumors. Int J Cancer (2021)

Pongor L, Munkácsy G, et al. Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting, Scienfic Reports (2020)

Menyhárt, Carouso-Peck et al: Contingent parental responses are naturally associated with zebra finch song learning, Animal Behaviour (2020)

Győrffy B et al: Research funding: past performance is a stronger predictor of future scientific output than reviewer scores Journal of Informetrics (2020)

Győrffy B et al. Is there a Golden Age in publication activity? – an analysis of age-related scholarly performance across all scientific disciplines Scientometrics (2020)

Menyhárt O and Győrffy B: Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches, Cancer and Metastasis Reviews (2020)

Fan J-B, Győrffy B, et al: Type I Interferon Regulates a Coordinated Gene Network to Enhance Cytotoxic T Cell-Mediated Tumor Killing, Cancer Discovery (2020)